Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples

Journal of Proteome Research

Volumn 14, Issue 10, 2015, Pages 4394-4401

  Hecht, Elizabeth S ^a   Scholl, Elizabeth H ^a   Walker, S Hunter ^a   Taylor, Amber D ^a   Cliby, William A ^b   Motsinger Reif, Alison A ^a   Muddiman, David C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

cancer biomarker; human plasma; INLIGHT; N linked glycosylation; ovarian cancer; relative quantification

Indexed keywords

ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; ELECTROSPRAY; FEMALE; FUCOSYLATION; GLYCAN CANCER BURDEN RATIO; HUMAN; IMMUNE RESPONSE; ION CHROMATOGRAPHY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MORPHOLOGY; ONCOLOGICAL PARAMETERS; OVARY CANCER; PRIORITY JOURNAL; SIALYLATION; TANDEM MASS SPECTROMETRY; BLOOD; CANCER STAGING; CARBOHYDRATE ANALYSIS; CHEMISTRY; GLYCOSYLATION; LIQUID CHROMATOGRAPHY; MOLECULAR GENETICS; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; STAINING;

FUCOSE; HYDRAZINE DERIVATIVE; POLYSACCHARIDE; SIALIC ACID DERIVATIVE; TUMOR MARKER;

BIOMARKERS, TUMOR; CARBOHYDRATE SEQUENCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; FUCOSE; GLYCOSYLATION; HUMANS; HYDRAZINES; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYSACCHARIDES; SIALIC ACIDS; STAINING AND LABELING; TANDEM MASS SPECTROMETRY;

EID: 84942861116     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00703     Document Type: Article

References (64)

1. United States Cancer Statistics: 1999-2010 Mortality, WONDER Online Database; United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute: Washington, D.C., 2013.
2. Buys, S. S.; Partridge, E.; Black, A.; Johnson, C. C.; Lamerato, L.; Isaacs, C.; Reding, D. J.; Greenlee, R. T.; Yokochi, L. A.; Kessel, B.; Crawford, E. D.; Church, T. R.; Andriole, G. L.; Weissfeld, J. L.; Fouad, M. N.; Chia, D.; O'Brien, B.; Ragard, L. R.; Clapp, J. D.; Rathmell, J. M.; Riley, T. L.; Hartge, P.; Pinsky, P. F.; Zhu, C. S.; Izmirlian, G.; Kramer, B. S.; Miller, A. B.; Xu, J. L.; Prorok, P. C.; Gohagan, J. K.; Berg, C. D.; Team, P. P. Effect of screening on ovarian cancer mortality the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial JAMA, J. Am. Med. Assoc. 2011, 305, 2295-2303 10.1001/jama.2011.766
3. Montagnana, M.; Danese, E.; Giudici, S.; Franchi, M.; Guidi, G. C.; Plebani, M.; Lippi, G. He4 in ovarian cancer: From discovery to clinical application Adv. Clin. Chem. 2011, 55, 1-20 10.1016/B978-0-12-387042-1.00001-0
4. Jacobs, I.; Bast, R. C. The CA-125 tumor-associated antigen-A review of the literature Hum. Reprod. 1989, 4, 1-12
5. Fisken, J.; Leonard, R. C. F.; Roulston, J. E. Immunoassay of CA125 in ovarian-cancer-A comparison of 3 assays for use in diagnosis and monitoring Dis. Markers 1989, 7, 61-67
6. Sarojini, S.; Tamir, A.; Lim, H.; Li, S.; Zhang, S.; Goy, A.; Pecora, A.; Suh, K. S. Early detection biomarkers for ovarian cancer J. Oncol. 2012, 2012, 1-15 10.1155/2012/709049
7. Biskup, K.; Braicu, E. I.; Sehouli, J.; Fotopoulou, C.; Tauber, R.; Berger, M.; Blanchard, V. Serum glycome profiling: A biomarker for diagnosis of ovarian cancer J. Proteome Res. 2013, 12, 4056-4063 10.1021/pr400405x
8. Zhang, X. W.; Wang, Y. S.; Qian, Y. F.; Wu, X.; Zhang, Z. J.; Liu, X. J.; Zhao, R.; Zhou, L.; Ruan, Y. Y.; Xu, J. J.; Liu, H. O.; Ren, S. F.; Xu, C. J.; Gu, J. X. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics PLoS One 2014, 9, e87978 10.1371/journal.pone.0087978
9. Anugraham, M.; Jacob, F.; Nixdorf, S.; Everest-Dass, A. V.; Heinzelmann-Schwarz, V.; Packer, N. H. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: Glycan structures reflect gene expression and DNA methylation status Mol. Cell. Proteomics 2014, 13, 2213-2232 10.1074/mcp.M113.037085
10. Goetz, J. A.; Mechref, Y.; Kang, P.; Jeng, M. H.; Novotny, M. V. Glycomic profiling of invasive and non-invasive breast cancer cells Glycoconjugate J. 2009, 26, 117-131 10.1007/s10719-008-9170-4
11. Kirmiz, C.; Li, B. S.; An, H. J.; Clowers, B. H.; Chew, H. K.; Lam, K. S.; Ferrige, A.; Alecio, R.; Borowsky, A. D.; Sulaimon, S.; Lebrilla, C. B.; Miyamoto, S. A serum glycomics approach to breast cancer biomarkers Mol. Cell. Proteomics 2006, 6, 43-55 10.1074/mcp.M600171-MCP200
12. Nakano, M.; Nakagawa, T.; Ito, T.; Kitada, T.; Hijioka, T.; Kasahara, A.; Tajiri, M.; Wada, Y.; Taniguchi, N.; Miyoshi, E. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers Int. J. Cancer 2008, 122, 2301-2309 10.1002/ijc.23364
13. Yue, T. T.; Goldstein, I. J.; Hollingsworth, M. A.; Kaul, K.; Brand, R. E.; Haab, B. B. The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays Mol. Cell. Proteomics 2009, 8, 1697-1707 10.1074/mcp.M900135-MCP200
14. Christiansen, M. N.; Chik, J.; Lee, L.; Anugraham, M.; Abrahams, J. L.; Packer, N. H. Cell surface protein glycosylation in cancer Proteomics 2014, 14, 525-546 10.1002/pmic.201300387
15. Reis, C. A.; Osorio, H.; Silva, L.; Gomes, C.; David, L. Alterations in glycosylation as biomarkers for cancer detection J. Clin. Pathol. 2010, 63, 322-329 10.1136/jcp.2009.071035
16. Live, D. H.; Kumar, R. A.; Beebe, X.; Danishefsky, S. J. Conformational influences of glycosylation of a peptide: A possible model for the effect of glycosylation on the rate of protein folding Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 12759-12761 10.1073/pnas.93.23.12759
17. Fan, H.; Meng, W.; Kilian, C.; Grams, S.; Reutter, W. Domain-specific N-glycosylation of the membrane glycoprotein dipeptidylpeptidase IV (CD26) influences its subcellular trafficking, biological stability, enzyme activity and protein folding Eur. J. Biochem. 1997, 246, 243-251 10.1111/j.1432-1033.1997.00243.x
18. Branza-Nichita, N.; Petrescu, A. J.; Negroiu, G.; Dwek, R. A.; Petrescu, S. M. N-glycosylation processing and glycoprotein folding-Lessons from the tyrosinase-related proteins Chem. Rev. 2000, 100, 4697-4711 10.1021/cr990291y
19. Ryšlavá, H.; Doubnerová, V.; Kavan, D.; Vaněk, O. Effect of posttranslational modifications on enzyme function and assembly J. Proteomics 2013, 92, 80-109 10.1016/j.jprot.2013.03.025
20. Chen, V. P.; Choi, R. C. Y.; Chan, W. K. B.; Leung, K. W.; Guo, A. J. Y.; Chan, G. K. L.; Luk, W. K. W.; Tsim, K. W. K. The assembly of proline-rich membrane anchor (PRiMA)-linked acetylcholinesterase enzyme glycosylation is required for enzymatic activity but not for oligomerization J. Biol. Chem. 2011, 286, 32948-32961 10.1074/jbc.M111.261248
21. Muta, K.; Fukami, T.; Nakajima, M.; Yokoi, T. N-glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity Biochem. Pharmacol. 2014, 87, 352-359 10.1016/j.bcp.2013.10.001
22. Bloem, K.; Vuist, I. M.; van der Plas, A. J.; Knippels, L. M. J.; Garssen, J.; Garcia-Vallejo, J. J.; van Vliet, S. J.; van Kooyk, Y. Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain PLoS One 2013, 8, e66266 10.1371/journal.pone.0066266
23. Del Grosso, F.; De Mariano, M.; Passoni, L.; Luksch, R.; Tonini, G. P.; Longo, L. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines BMC Cancer 2011, 11, 525-535 10.1186/1471-2407-11-525
24. Furukawa, K.; Ohkawa, Y.; Yamauchi, Y.; Hamamura, K.; Ohmi, Y.; Furukawa, K. Fine tuning of cell signals by glycosylation J. Biochem. 2012, 151, 573-578 10.1093/jb/mvs043
25. Gu, J.; Isaji, T.; Xu, Q.; Kariya, Y.; Gu, W.; Fukuda, T.; Du, Y. Potential roles of N-glycosylation in cell adhesion Glycoconjugate J. 2012, 29, 599-607 10.1007/s10719-012-9386-1
26. Bassagañas, S.; Carvalho, S.; Dias, A. M.; Pérez-Garay, M.; Ortiz, M. R.; Figueras, J.; Reis, C. A.; Pinho, S. S.; Peracaula, R. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function PLoS One 2014, 9, 1-14 10.1371/journal.pone.0098595
27. Gubbels, J. A. A.; Belisle, J.; Onda, M.; Rancourt, C.; Migneault, M.; Ho, M.; Bera, T. K.; Connor, J.; Sathyanarayana, B. K.; Lee, B.; Pastan, I.; Patankar, M. S. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors Mol. Cancer 2006, 5, 50 10.1186/1476-4598-5-50
28. Casey, R.; Oegema, T., Jr.; Skubitz, K.; Pambuccian, S.; Grindle, S.; Skubitz, A. N. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells Clin. Exp. Metastasis 2003, 20, 143-152 10.1023/A:1022670501667
29. Apweiler, R.; Hermjakob, H.; Sharon, N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database Biochim. Biophys. Acta, Gen. Subj. 1999, 1473, 4-8 10.1016/S0304-4165(99)00165-8
30. Laine, R. A. A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 10(12) structures for a reducing hexasaccharide: The isomer barrier to development of single-method saccharide sequencing or synthesis systems Glycobiology 1994, 4, 759-767 10.1093/glycob/4.6.759
31. Werz, D. B.; Ranzinger, R.; Herget, S.; Adibekian, A.; von der Lieth, C.-W.; Seeberger, P. H. Exploring the structural diversity of mammalian carbohydrates ('glycospace') by statistical databank analysis ACS Chem. Biol. 2007, 2, 685-691 10.1021/cb700178s
32. Harvey, D. J. Derivatization of carbohydrates for analysis by chromatography; electrophoresis and mass spectrometry J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879, 1196-1225 10.1016/j.jchromb.2010.11.010
33. Ruhaak, L. R.; Zauner, G.; Huhn, C.; Bruggink, C.; Deelder, A. M.; Wuhrer, M. Glycan labeling strategies and their use in identification and quantification Anal. Bioanal. Chem. 2010, 397, 3457-3481 10.1007/s00216-010-3532-z
34. Mechref, Y.; Zhou, S.; Hu, Y.; Hussein, A.; Tang, H. Quantitative glycomics by mass spectrometry and liquid chromatography-mass spectrometry Encyclopedia of Analytical Chemistry 2014, 1-22 10.1002/9780470027318.a9400
35. Zaia, J. Mass spectrometry and glycomics OMICS 2010, 14, 401-418 10.1089/omi.2009.0146
36. Walker, S. H.; Carlisle, B. C.; Muddiman, D. C. Systematic comparison of reverse phase and hydrophilic interaction liquid chromatography platforms for the analysis of N-linked glycans Anal. Chem. 2012, 84, 8198-8206 10.1021/ac3012494
37. Walker, S. H.; Papas, B. N.; Comins, D. L.; Muddiman, D. C. Interplay of permanent charge and hydrophobicity in the electrospray ionization of glycans Anal. Chem. 2010, 82, 6636-6642 10.1021/ac101227a
38. Walker, S. H.; Taylor, A. D.; Muddiman, D. C. Individuality normalization when labeling with isotopic glycan hydrazide tags (INLIGHT): A novel glycan-relative quantification strategy J. Am. Soc. Mass Spectrom. 2013, 24, 1376-1384 10.1007/s13361-013-0681-2
39. Bendiak, B.; Salyan, M. E.; Pantoja, M. Sequential removal of monosaccharides from the reducing end of oligosaccharides. 2. Fundamental studies of a reaction between hydrazino compounds and sugars having a glycosyl moiety on a carbon atom adjacent to a carbonyl group J. Org. Chem. 1995, 60, 8245-8256 10.1021/jo00130a026
40. Wu, J.; Xie, X.; Liu, Y.; He, J.; Benitez, R.; Buckanovich, R. J.; Lubman, D. M. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS J. Proteome Res. 2012, 11, 4541-4552 10.1021/pr300330z
41. Goodarzi, M. T.; Turner, G. A. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian-cancer Clin. Chim. Acta 1995, 236, 161-171 10.1016/0009-8981(95)06049-J
42. Saldova, R.; Piccard, H.; Perez-Garay, M.; Harvey, D. J.; Struwe, W. B.; Galligan, M. C.; Berghmans, N.; Madden, S. F.; Peracaula, R.; Opdenakker, G.; Rudd, P. M. Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression PLoS One 2013, 8, e71159 10.1371/journal.pone.0071159
43. Bast, R. C.; Hennessy, B.; Mills, G. B. The biology of ovarian cancer: new opportunities for translation Nat. Rev. Cancer 2009, 9, 415-428 10.1038/nrc2644
44. Walker, S. H.; Budhathoki-Uprety, J.; Novak, B. M.; Muddiman, D. C. Stable-isotope labeled hydrophobic hydrazide reagents for the relative quantification of N-linked glycans by electrospray ionization mass spectrometry Anal. Chem. 2011, 83, 6738-6745 10.1021/ac201376q
45. Functional Glycomics Gateway; Consortium for Functional Glycomics, 2012. http://www.functionalglycomics.org/ (accessed June 8, 2015).
46. Van Gorp, T.; Cadron, I.; Despierre, E.; Daemen, A.; Leunen, K.; Amant, F.; Timmerman, D.; De Moor, B.; Vergote, I. HE4 and CA125 as a diagnostic test in ovarian cancer: Prospective validation of the risk of ovarian malignancy algorithm Br. J. Cancer 2011, 104, 863-870 10.1038/sj.bjc.6606092
47. Anastasi, E.; Granato, T.; Falzarano, R.; Storelli, P.; Ticino, A.; Frati, L.; Panici, P. B.; Porpora, M. G. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer J. Ovarian Res. 2013, 6, 44 10.1186/1757-2215-6-44
48. Bereman, M. S.; Muddiman, D. C. The effects of abundant plasma protein depletion on global glycan profiling using NanoLC FT-ICR mass spectrometry Anal. Bioanal. Chem. 2010, 396, 1473-1479 10.1007/s00216-009-3368-6
49. Hua, S.; Williams, C. C.; Dimapasoc, L. M.; Ro, G. S.; Ozcan, S.; Miyamoto, S.; Lebrilla, C. B.; An, H. J.; Leiserowitz, G. S. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer J. Chromatogr. A 2013, 1279, 58-67 10.1016/j.chroma.2012.12.079
50. Kim, K.; Ruhaak, L. R.; Nguyen, U. T.; Taylor, S. L.; Dimapasoc, L.; Williams, C.; Stroble, C.; Ozcan, S.; Miyamoto, S.; Lebrilla, C. B.; Leiserowitz, G. S. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer Cancer Epidemiol., Biomarkers Prev. 2014, 23, 611-621 10.1158/1055-9965.EPI-13-1073
51. Lee, L. Y.; Thaysen-Andersen, M.; Baker, M. S.; Packer, N. H.; Hancock, W. S.; Fanayan, S. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification J. Proteome Res. 2014, 13, 4783-4795 10.1021/pr500331m
52. Machado, E.; Kandzia, S.; Carilho, R.; Altevogt, P.; Conradt, H. S.; Costa, J. N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin Glycobiology 2011, 21, 376-386 10.1093/glycob/cwq170
53. Takahashi, T.; Ikeda, Y.; Miyoshi, E.; Yaginuma, Y.; Ishikawa, M.; Taniguchi, N. α1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas Int. J. Cancer 2000, 88, 914-919 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1
54. Liu, J. C.; Cui, H. X.; Lin, Y.; Yue, L. L.; Zhao, X. M. Differential expression of the alpha 2,3-sialic acid residues in breast cancer is associated with metastatic potential Oncol. Rep. 2011, 25, 1365-1371 10.3892/or.2011.1192
55. Abbott, K. L.; Nairn, A. V.; Hall, E. M.; Horton, M. B.; McDonald, J. F.; Moremen, K. W.; Dinulescu, D. M.; Pierce, M. Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer Proteomics 2008, 8, 3210-3220 10.1002/pmic.200800157
56. Wang, P. H.; Lee, W. L.; Juang, C. M.; Yang, Y. H.; Lo, W. H.; Lai, C. R.; Hsieh, S. L.; Yuan, C. C. Altered mRNA expressions of sialyltransferases in ovarian cancers Gynecol. Oncol. 2005, 99, 631-639 10.1016/j.ygyno.2005.07.016
57. Allam, H.; Aoki, K.; Benigno, B. B.; McDonald, J. F.; Mackintosh, S. G.; Tiemeyer, M.; Abbott, K. L. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions J. Proteome Res. 2015, 14, 434-446 10.1021/pr501174p
58. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy Nat. Rev. Cancer 2012, 12, 252-264 10.1038/nrc3239
59. Brown, I. E.; Blank, C.; Kline, J.; Kacha, A. K.; Gajewski, T. F. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection J. Immunol. 2006, 177, 4521-4529 10.4049/jimmunol.177.7.4521
60. Boussiotis, V. A.; Barber, D. L.; Nakarai, T.; Freeman, G.; Gribben, J. G.; Bernstein, G. M.; D'Andrea, A. D.; Ritz, J.; Nadler, L. M. Prevention of T cell anergy by sgnaling through the gamma C chain of the IL-2 receptor Science 1994, 266, 1039-1042 10.1126/science.7973657
61. Harrd, K.; Damm, J. B. L.; Spruijt, M. P. N.; Bergwerff, A. A.; Kamerling, J. P.; Dedem, G. W. K.; Vliegenthart, J. F. G. The carbohydrate chains of the beta-subunit of human chorionic-gonadotropin produced by the choriocarcinoma cell-line bewo-novel o-linked and novel bisecting-glcnac-containing N-linked carbohydrates Eur. J. Biochem. 1992, 205, 785-798 10.1111/j.1432-1033.1992.tb16843.x
62. Goulutchassaing, C.; Bourrillon, R. Structural differences between complex-type Asn-linked glycan chains of glycoproteins in rat hepatocytes and zajdela hepatoma-cells Biochim. Biophys. Acta, Gen. Subj. 1995, 1244, 30-40 10.1016/0304-4165(94)00191-Y
63. Ceroni, A.; Dell, A.; Haslam, S. M. The GlycanBuilder: a fast, intuitive and flexible software tool for building and displaying glycan structures Source Code Biol. Med. 2007, 2, 3 10.1186/1751-0473-2-3
64. Domon, B.; Costello, C. E. A systematic nomenclature for carbohydrate fragmentations in FAB-MS MS spectra of glycoconjugates Glycoconjugate J. 1988, 5, 397-409 10.1007/BF01049915